SCHEMBL1707952

SCHEMBL1707952

O=C(O)[CH]Cc1ccc(O)c(O)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.57
HSD17B10 Q99714 5/20 0.57
TDP1 Q9NUW8 4/20 0.57
GAA P10253 4/20 0.57
MAPT P10636 4/20 0.57
HIF1A Q16665 3/20 0.57
POLB P06746 3/20 0.57
HPGD P15428 3/20 0.57
APEX1 P27695 3/20 0.57
PMP22 Q01453 3/20 0.57
BLM P54132 2/20 0.57
LMNA P02545 2/20 0.57
TSHR P16473 2/20 0.57
NFKB1 P19838 2/20 0.57
XDH P47989 1/20 0.57
RGS12 O14924 1/20 0.57
THPO P40225 1/20 0.57
GNAI1 P63096 1/20 0.57
LCK P06239 2/20 0.50
CA1 P00915 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28193207 0.82 KDM4E (0.55) KDM4EHSD17B10TDP1GAAMAPT
SCHEMBL29929036 0.79 XDH (0.65) KDM4EHSD17B10TDP1GAAMAPT
SCHEMBL891837 0.79 XDH (0.65) KDM4EHSD17B10TDP1GAAMAPT
SCHEMBL8067640 0.77 CA2 (0.52) MAPTBLMCA1CA2CA4
SCHEMBL26249726 0.76 XDH (0.68) KDM4EHSD17B10TDP1GAAMAPT
Hydroxychavicol SCHEMBL1657169 0.76 XDH (0.79) KDM4EHSD17B10TDP1GAAMAPT
SCHEMBL3093879 0.74 PTPRC (0.41) MEN1KMT2ATHRBPTPN1HDAC1
SCHEMBL29131163 0.74 CA1 (0.49) KDM4EHSD17B10TDP1GAAMAPT
Hydroxychavicol SCHEMBL22717104 0.73 XDH (0.81) KDM4EHSD17B10TDP1GAAMAPT
Hydroxychavicol SCHEMBL29440283 0.73 XDH (0.81) KDM4EHSD17B10TDP1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11219230-B2 Mixtures with stabilising properties SYMRISE AG (DE) 2022-01-11 US claimed
EP-3544445-B1 FOOD COMPOSITIONS CONTAINING VEGETABLE OIL AND MIXTURE WITH STABILISING PROPERTIES UNILEVER NV (NL) 2020-05-13 EP claimed
US-20190336423-A1 MIXTURES WITH STABILISING PROPERTIES SYMRISE AG (DE) 2019-11-07 US claimed
US-20190313659-A1 FOOD COMPOSITIONS CONTAINING VEGETABLE OIL AND MIXTURE WITH STABILISING PROPERTIES CONOPCO INC., D/B/A UNILEVER (US) 2019-10-17 US claimed
EP-3544445-A2 FOOD COMPOSITIONS CONTAINING VEGETABLE OIL AND MIXTURE WITH STABILISING PROPERTIES Unilever N.V. (NL) 2019-10-02 EP claimed
EP-3397072-B1 MIXTURES WITH STABILISING PROPERTIES SYMRISE AG (DE) 2019-07-24 EP claimed
EP-3397072-A1 MIXTURES WITH STABILISING PROPERTIES Symrise AG (DE) 2018-11-07 EP claimed
WO-2018096123-A1 MIXTURES WITH STABILISING PROPERTIES SYMRISE AG (DE) 2018-05-31 WO claimed
WO-2018095533-A1 MIXTURES WITH STABILISING PROPERTIES SYMRISE AG (DE) 2018-05-31 WO claimed
WO-2018096092-A2 FOOD COMPOSITIONS CONTAINING VEGETABLE OIL AND MIXTURE WITH STABILISING PROPERTIES UNILEVER N.V. (NL) 2018-05-31 WO claimed
EP-1867729-A1 Water soluble phenolics derivatives with dermocosmetic and therapeutic applications Libragen (FR) 2007-12-19 EP claimed
US-7268160-B2 Remedies TAKARA BIO, INC. (JP) 2007-09-11 US claimed
JP-5025083-A None JP disclosed
JP-1311077-A None JP disclosed
US-11219230-B2 Mixtures with stabilising properties SYMRISE AG (DE) 2022-01-11 US disclosed
EP-3544445-B1 FOOD COMPOSITIONS CONTAINING VEGETABLE OIL AND MIXTURE WITH STABILISING PROPERTIES UNILEVER NV (NL) 2020-05-13 EP disclosed
WO-2007144368-A2 WATER SOLUBLE PHENOLICS DERIVATIVES WITH DERMOCOSMETIC AND THERAPEUTIC APPLICATIONS LIBRAGEN (FR) 2007-12-21 WO disclosed
EP-1867729-A1 Water soluble phenolics derivatives with dermocosmetic and therapeutic applications Libragen (FR) 2007-12-19 EP disclosed
JP-H0525083-A 1,2-DIHYDROXYNAPHTHALENE-2,3-DICARBOXYLIC ACID DERIVATIVE KANEBO LTD 1993-02-02 JP disclosed
JP-H01311077-A BENZOFURANYLPROPENOIC ACID DERIVATIVE KANEBO LTD 1989-12-15 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11219230-B2 Mixtures with stabilising properties LPO, TAS2R50, TAS2R10 KDM4E 3493/4885HSD17B10 1475/4885TDP1 985/4885
US-20190336423-A1 MIXTURES WITH STABILISING PROPERTIES LPO, TAS2R50, TAS2R10 KDM4E 3493/4885HSD17B10 1475/4885TDP1 985/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.